Home/Filings/4/0000914190-17-000163
4//SEC Filing

Cardiovascular Systems Inc 4

Accession 0000914190-17-000163

CIK 0001180145operating

Filed

Jun 1, 8:00 PM ET

Accepted

Jun 2, 4:07 PM ET

Size

14.0 KB

Accession

0000914190-17-000163

Insider Transaction Report

Form 4
Period: 2017-05-31
Koehn Paul A
VP of Manufacturing
Transactions
  • Exercise/Conversion

    Common Stock

    2017-05-31$7.90/sh+12,940$102,22696,929 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2017-05-3112,9400 total
    Exercise: $7.90Exp: 2017-10-08Common Stock (12,940 underlying)
  • Exercise/Conversion

    Common Stock

    2017-05-31$12.15/sh+7,060$85,779103,989 total
  • Sale

    Common Stock

    2017-05-31$29.98/sh20,000$599,66083,989 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2017-05-317,06017,060 total
    Exercise: $12.15Exp: 2017-12-11Common Stock (7,060 underlying)
Holdings
  • Stock Option (right to buy)

    Exercise: $8.75Exp: 2019-03-01Common Stock (8,087 underlying)
    8,087
Footnotes (3)
  • [F1]Includes 602 shares acquired under Cardiovascular Systems, Inc.'s stock purchase plan on December 31, 2016.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.96 to $30.01 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc., or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F3]Fully exercisable.

Issuer

Cardiovascular Systems Inc

CIK 0001180145

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001180145

Filing Metadata

Form type
4
Filed
Jun 1, 8:00 PM ET
Accepted
Jun 2, 4:07 PM ET
Size
14.0 KB